Orexo AB (Sweden) Today
| ORX Stock | SEK 16.92 0.54 3.30% |
Performance10 of 100
| Odds Of DistressLess than 33
|
Orexo AB is selling for under 16.92 as of the 17th of April 2024; that is 3.30 percent up since the beginning of the trading day. The stock's last reported lowest price was 16.0. Orexo AB has about a 33 percent probability of financial distress in the next few years of operation but had a somewhat ok performance during the last 90 days. Equity ratings for Orexo AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of April 2022 and ending today, the 17th of April 2024. Click here to learn more.
Orexo AB , a specialty pharmaceutical company, develops products based on proprietary drug delivery technology. Orexo AB was founded in 1995 and is headquartered in Uppsala, Sweden. Orexo AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 34.35 M outstanding shares. More on Orexo AB
Moving together with Orexo Stock
| 0.61 | VOLV-A | AB Volvo | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Orexo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Orexo AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Orexo AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Pres CEO | Nikolaj Sorensen |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Orexo AB (ORX) is traded on Stockholm Exchange in Sweden and employs 126 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 612.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orexo AB's market, we take the total number of its shares issued and multiply it by Orexo AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Orexo AB operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 34.35 M outstanding shares.
Orexo AB has accumulated about 697 M in cash with (156.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Orexo AB Probability Of Bankruptcy
Ownership AllocationOrexo AB has a total of 34.35 Million outstanding shares. 30% of Orexo AB outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Orexo Ownership Details
Orexo Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Orexo AB jumping above the current price in 90 days from now is roughly 2.4%. The Orexo AB probability density function shows the probability of Orexo AB stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Orexo AB has a beta of -0.1125. This indicates as returns on the benchmark increase, returns on holding Orexo AB are expected to decrease at a much lower rate. During a bear market, however, Orexo AB is likely to outperform the market. Additionally, orexo AB has an alpha of 0.2213, implying that it can generate a 0.22 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Orexo AB to move above the current price in 90 days from now is roughly 2.4 (This Orexo AB probability density function shows the probability of Orexo Stock to fall within a particular range of prices over 90 days) .
Orexo AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Orexo AB market risk premium is the additional return an investor will receive from holding Orexo AB long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Orexo AB. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Orexo AB's alpha and beta are two of the key measurements used to evaluate Orexo AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.57 | |||
| Semi Deviation | 1.59 | |||
| Standard Deviation | 2.17 | |||
| Variance | 4.69 |
Orexo Stock Against Markets
Picking the right benchmark for Orexo AB stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Orexo AB stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Orexo AB is critical whether you are bullish or bearish towards Orexo AB at a given time. Please also check how Orexo AB's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Orexo AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Orexo AB Corporate Directors
Orexo AB corporate directors refer to members of an Orexo AB board of directors. The board of directors generally takes responsibility for the Orexo AB's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Orexo AB's board members must vote for the resolution. The Orexo AB board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Henrik Hansen | Director | Profile | |
| David Colpman | Director | Profile | |
| Staffan Lindstrand | Director | Profile | |
| Michael Shalmi | Director | Profile |
How to buy Orexo Stock?
Before investing in Orexo AB, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Orexo AB. To buy Orexo AB stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Orexo AB. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Orexo AB stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Orexo AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Orexo AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Orexo AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Orexo AB?
The danger of trading Orexo AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Orexo AB is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Orexo AB. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Orexo AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orexo AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Orexo Stock analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |